AGL (agilon health, inc.) Stock Analysis - Community

agilon health, inc. (AGL) is a publicly traded Healthcare sector company. As of May 21, 2026, AGL trades at $80.01 with a market cap of $1.45B and a P/E ratio of 0.00. AGL moved -8.59% today. Year to date, AGL is +367.52%; over the trailing twelve months it is +30.55%. Its 52-week range spans $7.48 to $152.00. Analyst consensus is neutral with an average price target of $37.46. Rallies surfaces AGL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

How does the Rallies community trade AGL?

Rallies community data for AGL shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.

AGL Key Metrics

Key financial metrics for AGL
MetricValue
Price$80.01
Market Cap$1.45B
P/E Ratio0.00
EPS$0.00
Dividend Yield0.11%
52-Week High$152.00
52-Week Low$7.48
Volume28
Avg Volume0
Revenue (TTM)$5.82B
Net Income$-354.54M
Gross Margin0.00%

Latest AGL News

Recent AGL Insider Trades

  • Shaker Benjamin bought 500.00K (~$301.05K) on Mar 2, 2026.
  • Wulf John William bought 81.00K (~$50.94K) on Nov 12, 2025.
  • McLoughlin Karen bought 25.00K (~$55.08K) on Dec 13, 2024.

AGL Analyst Consensus

15 analysts cover AGL: 0 strong buy, 4 buy, 8 hold, 3 sell, 0 strong sell. Consensus rating is neutral. Average price target: $37.46.

Common questions about AGL

How does the Rallies community trade AGL?
Rallies community data for AGL shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
Does Rallies show retail investor data for AGL?
Rallies shows anonymized community ownership, retail positioning, sentiment, and portfolio context for AGL when enough community data is available.
Is AGL research on Rallies investment advice?
No. Rallies provides research, data, and educational context for AGL. It does not provide personalized investment advice.
AGL

AGL